⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
🇬🇧
🧸 Product DE DK FR HR IE NO PL PT SE SI September 23, 2022

Citroen — Jumpy, Spacetourer

Passenger van / Light commercial vehicle

Risk level
Serious risk
Type
Injuries
Category
Motor vehicles
Hazard
The rear brake may be defective, which could result in a loss of service brake effectiveness which in turn could increase the risk of an accident.
Origin
United Kingdom

⚖️ Actions ordered by authorities

  • Measures ordered by economic operators (to: Manufacturer) Recall of the product from end users
🗄
Archived (older alert)
This alert was reported 1451 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
119 days in total
May 17, 2026 September 13, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? This is a notice about some Citroen vans. The rear brake might not work right. This could make the brakes weak or fail.

What's happening? Citroen has recalled some Jumpy and Spacetourer vans. The rear brake may be broken. This could cause accidents.

Does this affect me? If you own or drive one of these vans in Germany, Denmark, France, or other listed countries, this may affect you.

What should I do? Take your van to a Citroen dealer right away. Ask your dealer or a mechanic to check the brakes.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Brand(s) / product name(s)
Agency-published detail

Risk level: Serious risk · Type: Injuries · Category: Motor vehicles · Hazard: The rear brake may be defective, which could result in a loss of service brake effectiveness which in turn could increase the risk of an accident. · Origin: United Kingdom

First published
September 23, 2022
Last refreshed by us
3 months ago
Severity (as classified)
High
Official source
https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10006696

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

What is this product recall alert about?
Citroen — Jumpy, Spacetourer. Risk level: Serious risk · Type: Injuries · Category: Motor vehicles · Hazard: The rear brake may be defective, which could result in a loss of service brake effectiveness which in turn could increase the risk of an accident. · Origin: United Kingdom
When was this alert issued?
This alert was issued on September 23, 2022 by EU Safety Gate.
Which countries are affected?
The alert applies to the following countries: Germany, Denmark, France, Croatia, Ireland, Norway, Poland, Portugal, Sweden, and Slovenia.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you have this product at home, stop using it and return it to the point of purchase for a refund. Keep the receipt if you have one — most retailers refund without it for safety recalls.
Where can I find the official notice?
The full official notice is published on ec.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.